US FDA approves Otsuka's kidney disease drug
25/11/2025 20:10
Nov 25 (Reuters) - The U.S. Food and Drug Administration has approved Otsuka's 4578.T injectable drug to treat patients with a potentially life-threatening kidney disease, the health regulator's website showed on Tuesday. (Reporting by Siddhi Mahatole and Sriparna Roy in Bengaluru) ((siddhi.mahatole@thomsonreuters.com;))